Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 31, 2025MedicinaOpen Access

Pharmacologic Disruption: How Emerging Weight Loss Therapies Are Challenging Bariatric Surgery Guidelines

View Full Paper
Ask AI
Bookmark
Share

Authors

SASafi AlqatariAAAbrar AlwaheedMHManal Hasan

Discussion

Loading...

Member takes

Overview

Narrative review reveals novel pharmacotherapies challenge existing bariatric surgery criteria, suggesting new treatment algorithms.

Key Points

  • Bariatric surgery has historically been the most effective intervention for sustained weight loss in obesity.
  • Recent pharmacotherapies have achieved 15-25% weight loss, rivaling surgical outcomes for some patients.
  • Comparative analysis of surgery and next-gen drugs highlights efficacy, safety, and cost-effectiveness.
  • The need for a re-evaluation of bariatric guidelines is driven by advances in pharmacotherapy and personalized treatment approaches.

Cite This Study

Alqatari et al. (2025) studied this question.

synapsesocial.com/papers/689a0c5fe6551bb0af8cf6e9https://doi.org/10.3390/medicina61071292
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Current trends in bariatric surgery2025
  2. 2INNOVATIONS IN OBESITY TREATMENT – GLP – 1 PHARMACOTHERAPY AND BARIATRIC SURGERY2025
  3. 3A glimpse into the pipeline of anti-obesity medication development: combining multiple receptor pathways2025 · 4 citations
  4. 4Transforming Treatment: The Impact of Bariatric Surgery on Oral Drug Absorption2025
  5. 5The evolving role of metabolic and bariatric surgery in contemporary clinical practice2025